Viyash Scientific peers

Companies like Viyash Scientificlatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VIYASH₹224.55

Viyash Scientific Ltd.

· Pharma & Health
₹ CrorePeersAARTIDRUGSYATHARTHTHYROCARESUPRIYASTARSPARCSHILPAMEDRUBICONMcap ₹9,809 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
VIYASH
FY26
AARTIDRUGS
FY26
YATHARTH
FY26
THYROCARE
FY26
Peer
Average
Valuation — at last close
P/E54.90×◆ 21.02×50.73×50.19×40.65× +35%
P/B3.37×◆ 2.65×4.92×14.02×7.19× -53%
EV/EBITDA15.60×◆ 15.09×30.42×30.48×25.33× -38%
Market Cap₹9,809 Cr₹4,098 Cr₹8,896 Cr₹8,205 Cr₹7,067 Cr +39%
Growth
Revenue CAGR 3Y34.02%-1.89%◆ 48.11%16.33%20.85% +63%
Revenue CAGR 5Y◆ 20.23%3.55%—10.88%7.21% +180%
Net Income CAGR 3Y—5.43%◆ 38.45%36.27%26.72%
Revenue YoY (latest Q)◆ 114.39%19.01%52.33%25.07%32.14% +256%
Net Income YoY (latest Q)◆ 351.28%-7.12%8.05%-68.17%-22.41% +1667%
Profitability
EBITDA Margin19.08%12.05%24.20%◆ 31.61%22.62% -16%
Net Income Margin6.57%7.60%14.11%◆ 19.64%13.78% -52%
Return on Common Equity9.81%13.36%9.98%◆ 28.80%17.38% -44%
Return on Capital Employed17.53%13.34%10.91%◆ 33.68%19.31% -9%
Return on Assets7.21%7.23%8.49%◆ 22.62%12.78% -44%
Credit & Quality
Total Debt/Equity0.14×0.37×0.14×◆ 0.00×0.17× -18%
Interest Coverage6.05×7.19×31.26×◆ 72.66×37.04× -84%
Scale — latest FY
Revenue / Total Income₹3,420 Cr₹2,565 Cr₹1,207 Cr₹829 Cr₹1,534 Cr +123%
Net Income₹225 Cr₹195 Cr₹170 Cr₹163 Cr₹176 Cr +28%
Total Assets₹4,628 Cr₹2,815 Cr₹2,282 Cr₹747 Cr₹1,948 Cr +138%
EPS₹4.09₹21.36₹18.2₹10.27₹16.61 -75%
Book Value per Share₹66.64₹169.7₹187.55₹36.78₹131.34 -49%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.